Clinical trial
How to Optimize the Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
NCT03950544 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- How to Optimize the Combined Antibiotic Therapy for Carbapenem Resistant Klebsiella Pneumoniae
- Lead sponsor
- Shanghai 10th People's Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- December 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic resistant infection